TR200100805T2 - Tetrahidropiridoeterler - Google Patents

Tetrahidropiridoeterler

Info

Publication number
TR200100805T2
TR200100805T2 TR2001/00805T TR200100805T TR200100805T2 TR 200100805 T2 TR200100805 T2 TR 200100805T2 TR 2001/00805 T TR2001/00805 T TR 2001/00805T TR 200100805 T TR200100805 T TR 200100805T TR 200100805 T2 TR200100805 T2 TR 200100805T2
Authority
TR
Turkey
Prior art keywords
tetrahidropiridoet
prevention
compounds
formula
treatment
Prior art date
Application number
TR2001/00805T
Other languages
English (en)
Turkish (tr)
Inventor
Postius Stefan
Simon Wolfgang-Alexander
Grundler Gerhard
Hanauer Guido
Huber Reinhard
Kromer Wolfgang
Sturm Ernst
Senn-Bilfinger Jong
Original Assignee
Byk Gulden Lomberg Chemische Fabr�K Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabr�K Gmbh filed Critical Byk Gulden Lomberg Chemische Fabr�K Gmbh
Publication of TR200100805T2 publication Critical patent/TR200100805T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
TR2001/00805T 1998-09-23 1999-09-17 Tetrahidropiridoeterler TR200100805T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98117988 1998-09-23
DE19843504 1998-09-23

Publications (1)

Publication Number Publication Date
TR200100805T2 true TR200100805T2 (tr) 2001-08-21

Family

ID=26049024

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00805T TR200100805T2 (tr) 1998-09-23 1999-09-17 Tetrahidropiridoeterler

Country Status (31)

Country Link
US (4) US6436953B1 (cg-RX-API-DMAC7.html)
EP (1) EP1115725B1 (cg-RX-API-DMAC7.html)
JP (1) JP4145492B2 (cg-RX-API-DMAC7.html)
KR (1) KR100668400B1 (cg-RX-API-DMAC7.html)
CN (2) CN1155598C (cg-RX-API-DMAC7.html)
AT (1) ATE231862T1 (cg-RX-API-DMAC7.html)
AU (1) AU763463B2 (cg-RX-API-DMAC7.html)
BG (1) BG65195B1 (cg-RX-API-DMAC7.html)
BR (1) BR9914044A (cg-RX-API-DMAC7.html)
CA (1) CA2344251A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ292335B6 (cg-RX-API-DMAC7.html)
DE (1) DE69905178T2 (cg-RX-API-DMAC7.html)
DK (1) DK1115725T3 (cg-RX-API-DMAC7.html)
EA (1) EA005377B1 (cg-RX-API-DMAC7.html)
EE (1) EE04677B1 (cg-RX-API-DMAC7.html)
ES (1) ES2191464T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20032926B (cg-RX-API-DMAC7.html)
HK (1) HK1038360B (cg-RX-API-DMAC7.html)
HR (1) HRP20010224A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0102990A3 (cg-RX-API-DMAC7.html)
ID (1) ID28896A (cg-RX-API-DMAC7.html)
IL (2) IL142063A0 (cg-RX-API-DMAC7.html)
NO (1) NO317304B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ510610A (cg-RX-API-DMAC7.html)
PL (1) PL193616B1 (cg-RX-API-DMAC7.html)
PT (1) PT1115725E (cg-RX-API-DMAC7.html)
RS (1) RS50145B (cg-RX-API-DMAC7.html)
SI (1) SI1115725T1 (cg-RX-API-DMAC7.html)
SK (1) SK285165B6 (cg-RX-API-DMAC7.html)
TR (1) TR200100805T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000017200A1 (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000017200A1 (en) 1998-09-23 2000-03-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers
AU3966600A (en) * 1999-04-17 2000-11-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Haloalkoxy imidazonaphthyridines
CA2721484A1 (en) * 1999-05-12 2000-11-12 President And Fellows Of Harvard College Dopamine transporter imaging agents
WO2001072757A1 (en) * 2000-03-29 2001-10-04 Altana Pharma Ag Tricyclic imidazopyridines
JP2003528878A (ja) * 2000-03-29 2003-09-30 アルタナ ファルマ アクチエンゲゼルシャフト イミダゾピリジン誘導体のプロドラッグ
AU2002210563B2 (en) * 2000-10-25 2007-03-01 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
CZ20032398A3 (cs) * 2001-03-08 2004-02-18 Astrazeneca Ab Nové použití derivátů 6-karboxamidoimidazo [1,2-a] pyridinu
ATE336493T1 (de) 2001-08-02 2006-09-15 Altana Pharma Ag Tricyclische epoxide
CN1656096A (zh) * 2001-08-03 2005-08-17 奥坦纳医药公司 用于治疗胃肠病症的烷基-取代的咪唑吡啶
US20040235882A1 (en) * 2001-08-03 2004-11-25 Jorg Senn-Bilfinger Amino-substituted imidazopyridines for the treatment of gastrointestial diseases
HRP20040834A2 (en) 2002-02-15 2005-06-30 Altana Pharma Ag Tricyclic n-acyl compounds
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
WO2003094967A2 (en) * 2002-05-07 2003-11-20 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
HRP20050528A2 (en) 2002-11-19 2006-06-30 Altana Pharma Ag 8-substituted imidazopyridines
ES2312844T3 (es) 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
PL375933A1 (en) * 2002-12-20 2005-12-12 Altana Pharma Ag 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines
BRPI0407541A (pt) * 2003-02-17 2006-02-14 Altana Pharma Ag combinações e uso de compostos farmaceuticamente ativos selecionados
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
CA2526566A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
CA2537182A1 (en) * 2003-08-29 2005-03-10 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastrointestinal motility disorders
WO2005025578A1 (en) 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
EP1682133A1 (en) * 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
WO2005058894A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AR047605A1 (es) * 2004-02-17 2006-01-25 Altana Pharma Ag Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
DK1784404T3 (da) 2004-09-03 2012-02-13 Yuhan Corp Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
DK1784402T3 (da) 2004-09-03 2011-11-14 Yuhan Corp Pyrrolo[3,2-c]pyridinderivater samt fremgangsmåder til deres fremstilling
ES2426920T3 (es) 2004-09-03 2013-10-25 Yuhan Corporation Derivados de pirrolo[3,2-B]piridina y procesos para su preparación
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
EP2452680B1 (en) 2009-07-09 2019-12-18 RaQualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
BR112014031396B1 (pt) * 2012-06-15 2019-11-26 Bio Pharm Solutions Co Ltd composto de sulfamato de fenilalquila e composição de relaxante muscular compreendendo o mesmo
US20160235724A1 (en) 2013-10-08 2016-08-18 Katairo Gmbh Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
EP0370056A1 (de) 1987-07-16 1990-05-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazole
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
JPH10505332A (ja) * 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング アシルイミダゾピリジン
BR9807883A (pt) * 1997-03-24 2000-02-22 Byk Gulden Lomberg Chem Fab Compostos de tetraidropirido
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
WO2000017200A1 (en) 1998-09-23 2000-03-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers

Also Published As

Publication number Publication date
ID28896A (id) 2001-07-12
US20020169320A1 (en) 2002-11-14
EP1115725A1 (en) 2001-07-18
CZ20011082A3 (cs) 2001-09-12
KR20010075223A (ko) 2001-08-09
NO317304B1 (no) 2004-10-04
EA200100315A1 (ru) 2001-10-22
BG65195B1 (bg) 2007-06-29
IL142063A (en) 2007-10-31
NO20011243L (no) 2001-03-12
GEP20032926B (en) 2003-03-25
EE04677B1 (et) 2006-08-15
US6696460B2 (en) 2004-02-24
NO20011243D0 (no) 2001-03-12
HK1038360B (en) 2003-05-16
EA005377B1 (ru) 2005-02-24
SI1115725T1 (en) 2003-06-30
US6436953B1 (en) 2002-08-20
BR9914044A (pt) 2001-12-04
AU6192099A (en) 2000-04-10
JP2002526499A (ja) 2002-08-20
HUP0102990A2 (hu) 2002-01-28
PT1115725E (pt) 2003-06-30
IL142063A0 (en) 2002-03-10
SK3992001A3 (en) 2001-12-03
CN1319101A (zh) 2001-10-24
NZ510610A (en) 2003-07-25
CN100506821C (zh) 2009-07-01
AU763463B2 (en) 2003-07-24
CN1155598C (zh) 2004-06-30
SK285165B6 (sk) 2006-07-07
KR100668400B1 (ko) 2007-01-17
BG105270A (en) 2001-11-30
WO2000017200A1 (en) 2000-03-30
DK1115725T3 (da) 2003-06-23
EP1115725B1 (en) 2003-01-29
CA2344251A1 (en) 2000-03-30
YU21401A (sh) 2004-03-12
JP4145492B2 (ja) 2008-09-03
DE69905178D1 (de) 2003-03-06
HK1038360A1 (en) 2002-03-15
PL346617A1 (en) 2002-02-25
US7105676B2 (en) 2006-09-12
ES2191464T3 (es) 2003-09-01
RS50145B (sr) 2009-03-25
HUP0102990A3 (en) 2002-09-30
US20040162310A1 (en) 2004-08-19
EE200100172A (et) 2002-06-17
CZ292335B6 (cs) 2003-09-17
ATE231862T1 (de) 2003-02-15
DE69905178T2 (de) 2003-07-17
CN1560055A (zh) 2005-01-05
HRP20010224A2 (en) 2002-04-30
US7393860B1 (en) 2008-07-01
PL193616B1 (pl) 2007-02-28

Similar Documents

Publication Publication Date Title
YU21401A (sh) Tetrahidropiridoetri
ID30046A (id) Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin
ATE386742T1 (de) Imidazonaphthyridine
DK0971922T3 (da) Tetrahydropyrido-forbindelser
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
MXPA02009552A (es) Derivados de imidazopiridina alquilada.
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
TR199901386T2 (en) �midazopiridazinler.
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
TR199802270A2 (xx) S�lfonamid-ikame etmi� anelize 5-halka-bile�ikleri.
TR200001026T2 (tr) Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri.
ATE269313T1 (de) Tryptase-inhibitoren
ATE306283T1 (de) Biotin-derivate und ihre konjugaten mit chelatierungsmitteln
DK1244614T3 (da) Tryptase-inhibitorer
DE60120398D1 (de) Imidazopyridin-8-one
DE60220504D1 (en) Tryptasehemmer
PE61999A1 (es) Compuestos de tetrahidropiridina